2118
J. Li et al. / Journal of Organometallic Chemistry 696 (2011) 2116e2121
(s, 3H, NeCH3), 6.08 (m, 2H, NeCH2), 7.32e7.52 (m, 5H, Ph), 7.32
(brs, 1H, imidazol), 7.45 (brs, 1H, imidazol).Analysis calculated for
(C12H12N2O2): C 66.65%; H 5.59%; N 12.96%; O 14.80%. Found: C
66.61%; H 5.58%; N 12.98%; O 14.83%.
(C14H22RhN2Cl): C 47.14%; H 6.22%; N 7.85%. Found: C 47.11%; H
6.22%; N 7.88% (Yield: 88%).
2.3.3. Chloro(h
4-1,5-cyclooctadiene)(1-butyl-3-methylimidazole-
2-ylidene)rhodium(I) (3b)
2.2.8. 1-(4-Methylphenyl)-3-methylimidazolium-2-carboxylate (8a)
Synthesized by the reaction of 1-(4-methylphenyl)imidazole
and dimethyl carbonate (Yield: 67%). 1H NMR (400 MHz, CDCl3)
1H NMR (400 MHz, CDCl3)
d
(ppm): 6.81 (br d, J ¼ 4 Hz, 2H,
imidazol), 5.01 (m, 2H, COD CH), 4.49 (m, 2H, NeCH2), 4.07 (m,
3H, NeCH3), 3.34 (m, 1H, COD CH), 3.25 (m, 1H, COD CH), 2.38 (m,
4H, COD CH2), 1.98 (brm, 6H, 4HCOD CH2 and 2H Bu CH2), 1.29
(m, 2H, Bu CH2), 0.92 (t, J ¼ 8 Hz, 3H, CH3); 13C NMR (100 MHz,
d
(ppm): 2.25(s, 3H, PhCH3), 3.94 (s, 3H, NeCH3), 7.15e7.28 (m, 4H,
Ph), 7.32 (brs, 1H, imidazol), 7.35 (brs, 1H, imidazol). Analysis
calculated for (C12H12N2O2): C 66.65%; H 5.59%; N 12.96%; O 14.80%.
Found: C 66.63%; H 5.59%; N 12.98%; O 14.80%.
CDCl3)
d
: 13.8, 18.4, 28.6, 32.6, 33.0, 37.7(JNeC ¼ 7 Hz), 50.5
(JNeC ¼ 10 Hz), 67.2 (d, JRheC ¼ 14 Hz), 98.3 (d, JRheC ¼ 7 Hz), 120.1,
122.0, 181.8 (d, JCeRh 50 Hz). Analysis calculated for
¼
2.2.9. 1-(2,6-Diisopropylphenyl)-3-methylimidazolium-
2-carboxylate (9a)
(C16H26RhN2Cl): C 49.95%; H 6.81%; N 7.28%. Found: C 49.89%; H
6.90%; N 7.26% (Yield: 88%).
Synthesized by the reaction of 1-(2,6-diisopropylphenyl)imid-
azole and dimethyl carbonate (Yield: 62%). 1H NMR (400 MHz,
2.3.4. Chloro(h
4-1,5-cyclooctadiene)(1-hexyl-3-methylimidazole-
CDCl3)
d
(ppm): 1.21(d, J ¼ 8 Hz, 12H, CH(CH3)2), 2.50(m, 2H, CH
2-ylidene)rhodium(I) (4b)
(CH3)2), 3.92 (s, 3H, NeCH3), 7.32e7.52 (m, 3H, Ph), 7.32 (brs, 1H,
imidazol), 7.38 (brs, 1H, imidazol). Analysis calculated for
(C17H22N2O2): C 71.30%; H 7.74%; N 9.78%; O 11.17%. Found: C
71.28%; H 7.74%; N 9.79%; O 11.19%.
1H NMR (400 MHz, CDCl3)
d
(ppm): 6.81 (br d, J ¼ 4 Hz, 2H,
imidazol), 4.92 (m, 2H, COD CH), 4.46 (m, 2H, NeCH2), 4.07 (m, 3H,
NeCH3), 3.35 (m, 1H, COD CH), 3.24 (m, 1H, COD CH), 2.40 (m, 4H,
COD CH2), 1.29e2.00 (brm, 12H, 4HCOD CH2 and 8H CH2), 0.92
(t, J ¼ 8 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3)
d: 13.9, 11.3, 28.7,
2.2.10. 1-(2,4,6-Trimethylphenyl)-3-methylimidazolium-
2-carboxylate (10a)
29.8,30.3, 31.1, 32.1, 33.0, 37.8 (JNeC ¼ 7 Hz), 50.2 (JNeC ¼ 10 Hz), 67.6
(d, JRheC ¼ 14 Hz), 98.5 (d, JRheC ¼ 7 Hz), 120.3, 121.9, 182.1
(d, JCeRh ¼ 50 Hz). Analysis calculated for (C18H30RhN2Cl): C 52.37%;
H 7.33%; N 6.79%. Found: C 52.36%; H 7.31%; N 6.81% (Yield: 84%).
Synthesized by the reaction of 1-(2,4,6-trimethylphenyl)imid-
azole and dimethyl carbonate (Yield: 64%). 1H NMR (400 MHz,
CDCl3)
d (ppm):2.09 (s, 6H, CH3), 2.33 (s, 3H, CH3), 3.88 (s, 3H,
NeCH3), 7.08 (s, 2H, Ph), 7.35 (brs, 1H, imidazol), 7.41 (brs, 1H,
imidazol). Analysis calculated for (C14H16N2O2): C 68.83%; H 6.60%;
N 11.47%; O 13.10%. Found: C 68.81%; H 6.59%; N 11.49%; O 13.11%.
These data were consistent with those reported in the literature [24].
2.3.5. Chloro(
dazole-2-ylidene]rhodium(I) (5b)
1H NMR (400 MHz, CDCl3)
h
4-1,5-cyclooctadiene)[1-(2-propenyl)-3-methylimi-
d
(ppm): 6.82 (br d, J ¼ 4 Hz, 1H,
imidazol), 6.62 (br d, J ¼ 4 Hz, 1H, imidazol), 4.80 (m, 2H, COD CH),
4.15 (m, 2H, 1H NeCH2 and1H NCH2CH]CH2), 3.95 (m, 3H,
NeCH3), 3.67(d, J ¼ 12 Hz, 1H, NeCH2), 3.32 (m, 1H, COD CH), 3.24
(m, 1H, COD CH), 2.23 (m, 4H, COD CH2), 2.18e1.87 (brm, 6H,
2.3. Synthesis of rhodium N-heterocyclic carbene complexes
4HCOD CH2 and 2H NCH2CH]CH2); 13C NMR (100 MHz, CDCl3)
d:
These compound were prepared by stirring a mixture of
28.4, 32.1, 35.6, 38.1(JNeC ¼ 7 Hz), 47.2, 52.4(JNeC ¼ 10 Hz), 66.5 (d,
JRheC ¼ 14 Hz), 97.35(d, JRheC ¼ 7 Hz), 119.6, 123.2, 182.3 (d,
JCeRh ¼ 50 Hz). Analysis calculated for (C15H22RhN2Cl): C 48.86%; H
6.01%; N 7.60%. Found: C 48.84%; H 6.00%; N 7.62% (Yield: 93%).
500 mg (1.01 mmol) of bis(h
4-1,5-cyclooctadiene) dichloro-
dirhodium and 2.2 mmol of 1-alkyl-3–methyl imidazolium-2-
carboxylate in 10 mL of acetonitrile in a Schlenk flask for 40 min
at room temperature. The reaction mixture was evaporated
under reduced pressure and washed with diethyl ether
(3 ꢀ 10 mL). The yellow solid was dissolved in methylene chlo-
ride (2 mL) and purified by repeated recrystallization from
diethyl ether.
2.3.6. Chloro(h
4-1,5-cyclooctadiene)(1-phenyl-3-methylimidazole-
2-ylidene)rhodium(I) (6b)
1H NMR (400 MHz, CDCl3)
d (ppm): 8.03(m, 2H, Ph), 7.56e7.46
(m, 3H, Ph), 6.97 (br d, J ¼ 4 Hz, 1H, imidazol), 6.82 (br d, J ¼ 4 Hz,
1H, imidazol), 4.60 (m, 2H, COD CH), 4.03 (m, 3H, NeCH3), 3.28 (m,
1H, COD CH), 3.21 (m, 1H, COD CH), 2.34 (m, 4H, COD CH2), 1.97
2.3.1. Chloro(h
4-1,5-cyclooctadiene)(1-methyl-3-methylimidazole-
2-ylidene)rhodium(I) (1b)
(brm, 4H, 4HCOD CH2); 13C NMR (100 MHz, CDCl3)
d: 28.5, 32.5, 37.8
1H NMR (400 MHz, CDCl3)
d
(ppm): 6.72 (s, 2H, imidazol), 4.95
(JNeC ¼ 7 Hz), 67.1 (d, JRheC ¼ 14 Hz), 98.3 (d, JRheC ¼ 7 Hz), 120.1,
(m, 2H, COD CH), 4.00 (m, 6H, NeCH3), 3.33 (m, 2H, COD CH), 2.33
122.5, 125.8, 128.8, 129.0, 138.9, 181.9 (d, JCeRh ¼ 50 Hz), due to
(m, 4H, COD CH2), 1.89 (m, 4H, COD CH2); 13C NMR (100 MHz,
overlapping of signals, the carbon resonances from d 125 to 139
CDCl3)
d
: 28.9, 33.0, 37.6(JNeC ¼ 7 Hz), 67.6 (JRheC ¼ 15 Hz), 98.5
were listed. Analysis calculated for (C18H22RhN2Cl): C 53.42%; H
5.48%; N 6.92%. Found: C 53.40%; H 5.48%; N 6.93% (Yield: 89%).
(JRheC ¼ 7 Hz), 121.9, 182.8 (JCeRh ¼ 50 Hz). Analysis calculated for
(C13H20RhN2Cl): C 45.57%; H 5.88%; N 8.18%. Found: C 45.59%; H
5.86%; N 8.19% (Yield: 92%).
2.3.7. Chloro(h
4-1,5-cyclooctadiene)(1-benzyl-3-methylimidazole-
2-ylidene)rhodium(I) (7b)
2.3.2. Chloro(
h
4-1,5-cyclooctadiene)(1-ethyl-3-methylimidazole-
1H NMR (400 MHz, CDCl3)
d (ppm): 7.56e7.26 (m, 5H, Ph), 6.87
2-ylidene)rhodium(I) (2b)
(br d, J ¼ 4 Hz, 1H, imidazol), 6.60 (br d, J ¼ 4 Hz, 1H, imidazol), 5.58
(br s, 2H, CH2Ph), 4.87 (m, 2H, COD CH), 4.23 (m, 3H, NeCH3), 3.29
(m, 1H, COD CH), 3.25 (m, 1H, COD CH), 2.38 (m, 4H, COD CH2), 1.95
1H NMR (400 MHz, CDCl3)
d
(ppm): 6.82 (br d, J ¼ 4 Hz, 2H,
imidazol), 5.00 (m, 2H, COD CH), 4.47 (m, 2H, NeCH2), 3.72 (m, 3H,
NeCH3), 3.29 (m, 1H, COD CH), 3.25 (m, 1H, COD CH), 2.37 (m, 4H,
(brm, 4H, 4HCOD CH2); 13C NMR (100 MHz, CDCl3)
d: 28.8, 32.1, 37.8
COD CH2), 1.98 (brm, 4H, 4HCOD CH2), 1.22 (t, J ¼ 8 Hz, 3H, CH3); 13
C
(JNeC ¼ 7 Hz), 54.6(JNeC ¼ 11 Hz), 67.3 (d, JRheC ¼ 14 Hz), 98.7 (d,
JRheC ¼ 7 Hz), 119.9, 121.3, 128.1, 128.3, 129.0, 135.6181.9 (d,
JCeRh ¼ 50 Hz). Analysis calculated for (C19H24RhN2Cl): C 54.49%; H
5.78%; N 6.69%. Found: C 54.47%; H 5.77%; N 6.69% (Yield: 89%).
NMR (100 MHz, CDCl3)
d
: 15.8, 28.5, 32.5, 37.8(JNeC ¼ 7 Hz), 46.6
(JNeC ¼ 10 Hz), 67.1 (d, JRheC ¼ 14 Hz), 98.3 (d, JRheC ¼ 7 Hz), 120.3,
122.2, 181.9 (d, JCeRh 50 Hz). Analysis calculated for
¼